HighVista Strategies »

Crh shares owned by HighVista Strategies

Quarter-by-quarter ownership of Crh (CRH) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Crh

Tip: Access up to 7 years of quarterly data

All positions including Crh held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crh by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $966k 11k 86.26

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Merus N V (MRUS)
Microsoft Corporation (MSFT)
Arcellx Common Stock (ACLX)
Xpo Logistics Inc equity (XPO)
Nuvalent Inc-a (NUVL)
Ansys (ANSS)
Hess (HES)
Ideaya Biosciences (IDYA)
Juniper Networks (JNPR)
Sp Plus
Cerevel Therapeutics Hldng I (CERE)
Albertsons Cos Common Stock (ACI)

View all positions for HighVista Strategies

Top funds holding Crh

Vanguard Group
BlackRock
Barclays
FMR
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Select Equity
Cevian Capital II GP
Franklin Resources
Royal Bank of Canada
State Street Corporation
Greenhaven Associates
Amundi
Goldman Sachs Group
Invesco
Bank of New York Mellon

View all funds holding Crh